Bermuda-based consolidation vehicle is the third incarnation of Sir Clive Cowdery’s acquisitive Resolution
Resolution Life, an insurance consolidation vehicle founded by Sir Clive Cowdery, has completed a $3bn fundraising and added several of the investors who contributed, including JPMorgan and KKR, to its board.
Bermuda-based Resolution Life, founded in 2017, is Cowdery’s latest vehicle for buying and merging insurers.
A previous UK company, also called Resolution, acquired a series of businesses in the 2000s before merging with Britannic Group and then being sold to Hugh Osmond’s Pearl Group, later becoming Phoenix Group.
Cowdery relaunched the Resolution business a second time, buying Friends Life in 2009 and adding other businesses from Axa Sun Life and Bupa. This was then sold to Aviva in 2014.
This latest, third incarnation has acquired $5.7bn of life insurance policies from US insurer Symetra, and in October 2018, agreed to buy various insurance businesses from AMP in Australia and New Zealand for A$3bn.
In a statement on November 18, Resolution Life said it has raised $3bn from investors to finance further deals.
Representatives from JPMorgan, KKR, the Nippon Life Insurance Company, Singaporean sovereign wealth fund Temasek, and USS, the UK’s largest pension fund, will join its board — alongside an unnamed Middle Eastern sovereign fund.
Credit Suisse Asset Management acted as a placement agent on the fundraising.
Cowdery, who is executive chair of the company, said: “Resolution Life will continue to grow and release trapped capital and stranded costs for life insurers across a number of markets. I am delighted to welcome our cornerstone investors onto our board.”
Source: Financial News
Can’t stop reading? Read more
Top private equity news of the week
Top private equity news of the week BlackRock and Partners Group have launched a new private-markets investment account aimed at wealthy individuals, marking the first product to emerge from their strategic partnership announced in 2024. The separately managed account...
Thoma Bravo lines up potential $7bn exit from Imprivata
Thoma Bravo lines up potential $7bn exit from Imprivata Thoma Bravo is weighing a sale of healthcare identity software provider Imprivata in a process that could value the business at up to $7bn, according to sources cited by Reuters. The private equity firm is...
Intesa doubles down on capital returns, sidelines big deals through 2029
Intesa doubles down on capital returns, sidelines big deals through 2029 Intesa Sanpaolo has committed to returning about €50bn to shareholders through 2029, reinforcing a capital-light strategy that sidelines major M&A in favour of dividends, buybacks, and...